|
=====================================
THE MAGNIFIER - Electronic Newsletter
Issue #8, February 7, 2001
Produced by: Macular Degeneration Foundation
P.O. Box 9752, San Jose, CA 95157
http://www.eyesight.org
CONTENTS
1. FEB 27TH, PBS NOVA FEATURE
2. NEW TRIALS FOR "WET" AMD
3. UPDATED JUVENILE MACULAR DEGENERATION SECTION
=====================================
1. On February 27th, 2001, PBS NOVA will present "Cancer Warriors", featuring the research work being done
at Harvard Medical School, led by the famous cancer researcher Dr. Jonah Folkman. One of the team members, Dr. Robert D'Amato, MD, Ph.D., is this Foundation's Science and Research Advisor and is one of the world's
leading authorities on macular degeneration. The researchers have intensified their work in studies of the use of ANGIOGENESIS INHIBITORS, drugs that may provide benefit for people who have cancer, rheumatoid arthritis or
macular degeneration.
------------------------------------------------------------------
2. New trials have begun to investigate if angiogenesis inhibitors can effectively inhibit the growth of new
vessels in age-related macular degeneration.
See our "RESEARCH" section: "Angiogenesis Research" - Dr. Robert D'Amato (Harvard Medical School)
http://www.eyesight.org/Research/Angiogenesis_Research/angiogenesis_rese arch.html
------------------------------------------------------------------
3. Our understanding of Juvenile
Macular Degeneration is improving. The MD FOUNDATION's Director of Basic Research, Philip Filner, Ph.D., has updated our web site's JMD section to reflect the latest available information.
http://www.eyesight.org/All_About_MD/Juvenile_MD/juvenile_md.html
=============================
Note: the above information does not constitute medical advice. Only your physician or licensed
ophthalmologist can dispense medical advice based upon a complete and thorough evaluation of your specific and unique situation.
=============================
The MAGNIFIER is sent without charge. We hope that
it will continue to serve the interests of its subscribers. Contributions to the Macular Degeneration Foundation are appreciated and may be sent to P.O. Box 9752, San Jose, CA 95157
|
|
